Deccan Health Care Ltd
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]
- Market Cap ₹ 34.4 Cr.
- Current Price ₹ 13.9
- High / Low ₹ 24.4 / 13.0
- Stock P/E 15.6
- Book Value ₹ 44.0
- Dividend Yield 0.00 %
- ROCE 1.69 %
- ROE 1.18 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.32 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 18.4%
- Company has a low return on equity of 1.15% over last 3 years.
- Contingent liabilities of Rs.16.8 Cr.
- Promoter holding has decreased over last 3 years: -3.79%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.26 | 39.52 | 16.16 | 29.34 | 37.83 | 44.25 | 42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.13 | 89.72 | |
| 28.28 | 38.54 | 9.81 | 16.54 | 23.77 | 27.44 | 30.57 | 31.74 | 27.54 | 42.97 | 55.97 | 71.95 | 84.98 | |
| Operating Profit | 0.98 | 0.98 | 6.35 | 12.80 | 14.06 | 16.81 | 11.67 | 2.04 | 5.63 | 2.05 | 3.76 | 3.18 | 4.74 |
| OPM % | 3.35% | 2.48% | 39.29% | 43.63% | 37.17% | 37.99% | 27.63% | 6.04% | 16.97% | 4.55% | 6.29% | 4.23% | 5.28% |
| 0.09 | 0.09 | -0.17 | 0.05 | 2.07 | 0.08 | 0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Interest | 0.01 | 0.10 | 1.48 | 2.14 | 1.50 | 1.04 | 0.18 | 0.11 | 0.15 | 0.11 | 0.06 | 0.07 | 0.24 |
| Depreciation | 0.02 | 0.22 | 1.15 | 1.19 | 1.28 | 1.29 | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.45 |
| Profit before tax | 1.04 | 0.75 | 3.55 | 9.52 | 13.35 | 14.56 | 10.13 | 0.52 | 0.55 | 0.53 | 2.24 | 1.67 | 3.06 |
| Tax % | 17.31% | 30.67% | 0.28% | -0.21% | -0.15% | 0.62% | 0.39% | 25.00% | 40.00% | 26.42% | 32.59% | 28.14% | |
| 0.86 | 0.53 | 3.54 | 9.54 | 13.36 | 14.48 | 10.09 | 0.39 | 0.32 | 0.40 | 1.52 | 1.20 | 2.20 | |
| EPS in Rs | 1.61 | 0.99 | 3.39 | 7.38 | 9.90 | 9.22 | 6.42 | 0.25 | 0.20 | 0.23 | 0.75 | 0.51 | 0.88 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 31% |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -35% |
| 3 Years: | -20% |
| TTM: | 83% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -12% |
| 3 Years: | -25% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.33 | 5.33 | 10.43 | 12.93 | 13.50 | 15.71 | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 | 24.75 |
| Reserves | 1.24 | 11.08 | -2.03 | 9.21 | 32.68 | 50.43 | 60.52 | 60.91 | 61.23 | 64.61 | 76.66 | 83.13 | 84.21 |
| 0.00 | 10.46 | 13.94 | 10.94 | 10.90 | 1.41 | 1.30 | 1.03 | 1.25 | 1.55 | 1.41 | 1.15 | 1.33 | |
| 3.02 | 3.29 | 7.00 | 16.51 | 13.40 | 15.30 | 15.46 | 14.61 | 12.44 | 13.28 | 8.87 | 16.22 | 25.90 | |
| Total Liabilities | 9.59 | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 136.19 |
| 0.08 | 18.54 | 17.12 | 17.32 | 17.71 | 20.85 | 21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | 13.69 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 3.51 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| 9.51 | 11.62 | 12.22 | 32.25 | 49.26 | 62.00 | 71.74 | 72.31 | 72.09 | 79.62 | 91.62 | 109.54 | 122.49 | |
| Total Assets | 9.59 | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 136.19 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 3.04 | 2.28 | 12.92 | 2.62 | 2.68 | 0.22 | -0.57 | -6.59 | -12.48 | -6.60 | |
| 0.00 | 0.00 | 0.00 | -1.40 | -12.90 | -11.53 | -1.94 | -0.08 | -0.05 | 0.26 | -0.30 | -0.14 | |
| 0.00 | 0.00 | -2.91 | -0.95 | 0.21 | 13.07 | -1.77 | -0.37 | 0.07 | 5.06 | 13.64 | 8.01 | |
| Net Cash Flow | 0.00 | 0.00 | 0.13 | -0.08 | 0.23 | 4.16 | -1.03 | -0.23 | -0.55 | -1.27 | 0.86 | 1.27 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52.39 | 50.24 | 181.82 | 229.90 | 170.49 | 159.86 | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 61.26 |
| Inventory Days | 48.33 | 34.08 | 269.62 | 432.36 | 596.97 | 773.64 | 825.88 | 890.81 | 1,182.75 | 683.64 | 445.05 | 326.33 |
| Days Payable | 42.96 | 31.06 | 264.36 | 447.94 | 173.22 | 185.88 | 153.84 | 112.09 | 146.00 | 123.28 | 41.39 | 68.52 |
| Cash Conversion Cycle | 57.76 | 53.25 | 187.08 | 214.32 | 594.24 | 747.62 | 849.70 | 913.46 | 1,177.82 | 657.58 | 464.10 | 319.07 |
| Working Capital Days | 55.51 | 51.72 | -155.17 | 193.82 | 240.82 | 321.94 | 421.77 | 545.99 | 603.01 | 502.26 | 477.19 | 423.69 |
| ROCE % | 5.08% | 42.08% | 32.94% | 25.03% | 14.21% | 0.81% | 5.62% | 0.79% | 2.53% | 1.69% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
8h - News Paper Publication for Unaudited Financial Results for Quarter ended December 2025
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
13 Feb - Q3 revenue ₹2,303.20 Lakhs, PAT ₹95.07 Lakhs; nine-month revenue ₹6,890.61 Lakhs; UAE registration, export planned Q1 next FY.
-
Board Meeting Outcome for Considered And Approved Standalone And Consolidated Financial Results For Quarter Ended 31.12.2025
13 Feb - Approved unaudited quarterly and nine-month results ended 31 Dec 2025; standalone PAT Rs95.07L, consolidated PAT Rs100.25L.
-
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Result For The Quarter Ended 31St December 2025 And To Consider And Approve Appointment Of Independent Director(S)
10 Feb - Board meeting 13 Feb 2026 to approve unaudited results for quarter ended 31 Dec 2025 and appoint independent director(s).
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
21 Jan - RTA certificate: all shares dematerialized; no demat/remat requests in quarter ended 31 Dec 2025.
Business Overview:[1]
DHL is a Nutraceutical and wellness product company. Its food pills and meals are categorized under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com